The way has been largely cleared for the rollout of Pfizer’s respiratory syncytial virus (RSV) vaccine to ... by both the FDA and CDC for use in infants and young children.

RSV is a respiratory infection, most common in young children and newborns. Most cases are mild with cold-like symptoms. Some cases are more severe. The Centers for Disease Control (CDC ...